As of 2025-03-18, the Relative Valuation of Treace Medical Concepts Inc (TMCI) is (31.31) USD. This relative valuation is based on P/E multiples. With the latest stock price at 7.97 USD, the upside of Treace Medical Concepts Inc based on Relative Valuation is -492.9%.
The range of the Relative Valuation is (28.73) - (30.25) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 32.3x - 38.8x | 38.0x |
| Forward P/E multiples | 29.7x - 34.0x | 32.3x |
| Fair Price | (28.73) - (30.25) | (31.31) |
| Upside | -460.5% - -479.5% | -492.9% |
| Date | P/E |
| 2025-03-14 | -8.93 |
| 2025-03-13 | -8.92 |
| 2025-03-12 | -9.19 |
| 2025-03-11 | -9.31 |
| 2025-03-10 | -9.25 |
| 2025-03-07 | -9.63 |
| 2025-03-06 | -9.80 |
| 2025-03-05 | -10.26 |
| 2025-03-04 | -9.93 |
| 2025-03-03 | -9.84 |
| 2025-02-28 | -10.04 |
| 2025-02-27 | -10.26 |
| 2025-02-26 | -10.90 |
| 2025-02-25 | -10.80 |
| 2025-02-24 | -10.77 |
| 2025-02-21 | -10.53 |
| 2025-02-20 | -10.85 |
| 2025-02-19 | -11.29 |
| 2025-02-18 | -11.49 |
| 2025-02-14 | -11.32 |
| 2025-02-13 | -11.32 |
| 2025-02-12 | -11.03 |
| 2025-02-11 | -11.23 |
| 2025-02-10 | -11.49 |
| 2025-02-07 | -11.51 |
| 2025-02-06 | -11.55 |
| 2025-02-05 | -11.84 |
| 2025-02-04 | -11.81 |
| 2025-02-03 | -10.89 |
| 2025-01-31 | -11.29 |
| 2025-01-30 | -11.27 |
| 2025-01-29 | -11.71 |
| 2025-01-28 | -10.62 |
| 2025-01-27 | -10.90 |
| 2025-01-24 | -10.36 |
| 2025-01-23 | -10.51 |
| 2025-01-22 | -10.59 |
| 2025-01-21 | -10.41 |
| 2025-01-17 | -9.78 |
| 2025-01-16 | -9.27 |
| 2025-01-15 | -9.51 |
| 2025-01-14 | -9.00 |
| 2025-01-13 | -9.39 |
| 2025-01-10 | -8.20 |
| 2025-01-08 | -8.50 |
| 2025-01-07 | -8.59 |
| 2025-01-06 | -8.75 |
| 2025-01-03 | -8.87 |
| 2025-01-02 | -8.84 |
| 2024-12-31 | -8.36 |